That's crucial, due to the fact that the way a protein in the body folds figures out if a pharmaceutical will have the ability to bind to that protein and work. To put it simply, we have to know how these proteins fold if we want a drug to work. Historically, this has been an experimental process (last year). Today, Alpha, Fold can forecast protein folding with 92. 4% precision. That's going to make it much simpler to develop drugs that do what they're developed to do. This was a development almost nobody saw. But it's going to have profound ramifications for treating disease. I forecast that Alpha, Fold will be 98% precise by the end of 2021.
And, naturally, there will be lots of investment opportunities in this space, too. Moving topics It's going to be a great year for bitcoin. I'm bullish on it in 2021 (jeff brown stock picks 2021). That stated, I still think bitcoin will continue to be volatile. We're close to all-time highs. I would not be surprised if it pulled back maybe considerably prior to going higher - democratic republic. I have actually been covering bitcoin for a long period of time now. One of the first research reports I ever published was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that preliminary suggestion, I titled my report "What's the Big Deal With Bitcoin?" That shows you where the discussion was at the time. We were mainly informing readers. However that's not the big question any longer. Now we're seeing institutional cash lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, specific niche business. Mass, Mutual is a trusted 170-year-old institution. So consider that. In five years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
Which's a huge reason I'm bullish on it this year. jeff brown investment prediction. Regards, Jeff Brown, Editor, The Bleeding Edge I have a benefit prediction 2020 was a record year for IPOs. 552 U.S. companies went public the most in more than 20 years. These companies raised a total of $172 billion. That's an all-time high beating the previous yearly record by 43%. I anticipate 2021 will be another record year in IPOs. There are so numerous great personal companies on the verge of hitting the public markets And I've been working on a new method for you to invest even prior to these companies go public.
This opportunity has been constructing over the last couple of years. I can't wait to inform you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Occasion to discover all the information. Go right here to book your spot totally free.
Emma Walsh here, handling editor of the Journal. Regular Journal readers know that tech isn't our typical beat (second wave). And when it comes to tech investing, we leave it to the experts. Thankfully, we have numerous such experts in our Rolodex. Our associate Jeff Brown will recognize to our longtime readers. He is among the most accomplished tech investing specialists we understand (second wave). In truth, he had several triple-digit returns in his Brownstone Research portfolios in 2015. Here's what Jeff thinks the tech sector will bring us in 2021 Each year, I like to have a look at the big image and predict what's simply around the corner.
That includes things like 5G networks, biotech, artificial intelligence, and a lot more. These trends are experiencing rapid growth and producing amazing chances for investors. I wish to ensure all our readers are gotten ready for what's next. And with that in mind, let me draw the image of what I see can be found in the next 12 months Our brand-new 5G (fifth-generation) cordless networks are a subject I have actually been covering for years now. jeff brown prediction. But regardless of what lots of readers might think, this is a pattern that's simply starting. Despite the fact that the COVID-19 pandemic interfered with supply chains in 2015, an impressive 250 million 5G-enabled gadgets were still sold.
And all of this ultimately led to Apple delaying the release of the 5G-enabled i, Phone 12 by two months (jeff brown 2021 stock predictions). Losing 2 months of production and sales truly affects the number of 5G devices are sold in the fiscal year. When you think about all of that, selling 250 million systems is remarkable. More significantly, the hold-ups caused by the pandemic produced a lots of suppressed demand. And that demand is now going to be pressed into 2021. In reality, I forecast that more than 500 million 5G devices will be delivered in 2021 - united states. Which's not my only 5G forecast When I've talked about 5G in the past, I've explained its 3 various phases.
In Phase Two, 5G gadgets go on sale. 5G phones and other products begin to reach consumers. And in Phase Three, 5G services begin to be offered (the legacy report prediction). That's when we begin to see applications working on 5G networks. Consider things like huge multiplayer games over a cellphone. That's not possible with 4G. It will be with 5G. And my 2nd 5G prediction for 2021 is that we will begin Stage Three by this summer season. This starts something of a virtuous cycle: Many individuals do not really care about the technology. But they will care if there are exciting applications that can just be accessed with a 5G phone.
That leads to more 5G apps being established. In truth, 5G is going to open a suite of unbelievable applications: self-driving cars, the Web of Things, robotic surgery, and more. All of these innovations require 5G. The financial investment opportunities moving forward will be enormous. Stepping away from 5G, the next essential innovation I predict in 2021 is CRISPR genetic editing. CRISPR represents "clustered regularly interspaced short palindromic repeat." It's a mouthful. But it is among the most exciting developments in biotechnology. At a high level, CRISPR is an innovation that can edit our genetic makeup as if it were software application.
The program can crash or not work correctly. CRISPR utilizes a similar idea however with our genetic code. "Typos" in our genome can cause illness. CRISPR can remedy these "typos." For years, CRISPR was primarily a niche innovation that wasn't well understood. And during that time, there were really just three business operating in this space. But things are altering. CRISPR is no longer simply theoretical. We're seeing real outcomes. We're dealing with illness and seeing that this innovation simply works. And as a result, a "2nd crop" of early-stage CRISPR companies is going public and providing extraordinary returns. This whole industry is efficiently a greenfield opportunity.
There's room for numerous business to exist in this area. genetic sequencing companies jeff brown. And there will be more. That's my prediction for CRISPR in 2021. I forecast that two or 3 more hereditary editing companies will hold their IPOs. Sticking with biotechnology, we are seeing fantastic things taking place at the merging of biotech and expert system (AI). Google's AI subsidiary, Deep, Mind, just announced at the end of 2020 that its newest Alpha, Fold software can properly forecast the folding of a protein based exclusively on its amino acid series with 92. 4% precision. That is essential since the method a protein in the body folds determines if a pharmaceutical will have the ability to bind to that protein and work.
Historically, this has actually been a trial-and-error process. Today, Alpha, Fold can predict protein folding with 92. 4% precision. That's going to make it a lot easier to create drugs that do what they're created to do. And here's my next forecast. I forecast that Alpha, Fold will be 98% accurate by the end of 2021. And we will see not just one but several drug treatments produced using this technology. This was among those breakthroughs that nearly no one observed. However it's going to have profound ramifications for treating disease. And, obviously, there will be a lot of investment chances in this area, too.
It's going to be a good year for bitcoin. I'm bullish on it in 2021. That stated, I still believe bitcoin will continue to be volatile. We're close to all-time highs. I would not be shocked if it pulled back possibly significantly prior to going greater. I have actually been covering bitcoin for a long time now. One of the very first research study reports I ever published was on bitcoin - jeff brown predictions for 2021. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on financial investment for any person who followed my recommendation. However at the time of that initial suggestion, I entitled my report, "What's the Big Deal With Bitcoin?" That shows you where the discussion was at the time.
But no one is asking that concern any longer. Now, we're seeing institutional cash finally taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, specific niche enterprise. black sea. Mass, Mutual is a 150-year-old institution. So think about that. In five years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a big reason why I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more reward forecast In 2021, we're going to have another record year in IPOs. One website reports that Jeff Brown deserves about $27. 5 million and claims the info is up to date since February 2021, however we could not separately verify this claim. Given Jeff Brown's past, he likely has a significant net worth, but we can't hammer down an accurate figure at this minute. Brown is best understood for his sage-like ability to select winning innovation stocks. He invested more than 25 years looking into technology business like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's comprehensive experience provides him an exceptional perspective on the market. He's constantly on the hunt for new opportunities, and he shares a number of his best picks in the Near Future Report.
That's high appreciation, however it's not absurdly reasoned. Brown has an excellent reputation as a stock-picker, and he effectively forecasted a few of the most significant economic occasions of the previous 20 years. Although he does not appear to release his choices to the public, the service's success is a direct indication of Brown's stock-picking prowess. Nobody on Wall Street gets it best each time, however Jeff Brown's accurate forecasts have made him legions of dedicated followers. That says a lot about his capability. The Near Future Report is published by Brownstone Research study, a prominent financial research study publisher. Brownstone Research study uses a number of research services with a variety of specializations - genetic sequencer stock jeff brown.
The business is also affiliated with Bonner & Partners, another well-respected research study publisher - white house. On its website, Brownstone says its mission is to supply retail financiers with professional-grade research: "For too long, the very best financial investment research study has actually not been available to specific investors. It has actually been usually reserved for investment banks, hedge funds, private equity, and high-net-worth clients. united states. The mission of Brownstone Research is to make that sort of exclusive research study available to any financiers looking to gain an edge in the marketplaces. The objective is basic to deliver distinct and profitable financial investment research study discovered no place else." -Brownstone Research study website excerpt from the Jeff Brown is the founder of Brownstone Research study, and he likewise functions as the company's Chief Financial investment Analyst.
With Brown assisting the ship, Brownstone Research is a powerhouse publisher with lots to use its customers. After decades of steady success at the helm of top-tier companies like Tesla and Space, X, Elon Musk is a family name throughout the majority of America. If you know even a little bit about the market, you understand that he has a credibility as a King Midas of sorts. bleeding edge. Everything he touches relies on gold! Jeff is well conscious of Elon Musk's executive expertise, so he constantly has an eye out for the Silicon Valley rock star's next relocation. This time, Jeff has an early lead on Elon's next huge task.
In reality, Brown thinks S.A.V. jeff brown top biotech stock 2021. might be "the biggest pattern of the 2020s, and he's not alone. Take a look at these quotes from other popular S.A.V. bulls: Elon's next huge act will be marrying 2 advanced technologies: expert system and electrical cars and trucks. Musk hopes the combination will assist him establish the very first fully-autonomous, self-driving vehicles ever. It's nothing except the automotive industry's Holy Grail. As you know, electric cars and self-driving automobile stocks have actually been big this year, however the Wall Street machine has approved buzz without much tangible result. Regardless of an extreme increase in competition over the past few years, Brown still believes Musk has the best possibility of putting it all together.
tech could be the magic string that ties all of it together. S.A.V. represents Shared Autonomous Automobile, and it might be the future of transportation. Essentially, this technology would allow you to rent your car as a self-governing, self-driving taxi when you're not using it. You just leave the car and press a button on an app that informs the vehicle to "sign up with the fleet." Next thing you know, you're relaxing on your sofa while your cars and truck shuttles ride-sharers around town. Most importantly, you get to keep a hefty chunk of the profits. It sounds crazy, however it could be closed than you believe.